Table 3.

LVMI and prevalence of LVH in ARVD patients compared with control patients and stratified according to renal functional grouping

Control Group (n = 50)ARVD Group (n = 79)P
LVMI (g/m2)
    preserved renal function101.1 ± 24.9148.9 ± 45.5<0.05
    moderate renal failure110.8 ± 37.5184.9 ± 69.8<0.001
    severe renal failure126.7 ± 28.0188.3 ± 82.5<0.005
    P(between renal function categories)0.1390.171
Prevalence of LVH (%)
    preserved renal function33.368.8NS
    moderate renal failure43.582.8<0.05
    severe renal failure52.478.6NS
    P(between renal function categories)0.6730.173
Cholesterol (mmol/L)4.4 ± 1.04.7 ± 1.1NS
Calcium-phosphate product (mmol/L)3.0 ± 1.02.7 ± 0.7NS